Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Goodwill & Intangibles (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Goodwill & Intangibles for 16 consecutive years, with $135.1 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Goodwill & Intangibles changed N/A year-over-year to $135.1 million, compared with a TTM value of $135.1 million through Mar 2025, changed N/A, and an annual FY2024 reading of $177.2 million, up 225.41% over the prior year.
  • Goodwill & Intangibles was $135.1 million for Q1 2025 at Cross Country Healthcare, down from $177.2 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $208.0 million in Q4 2022 and bottomed at $1.7 million in Q2 2022.
  • Average Goodwill & Intangibles over 5 years is $90.3 million, with a median of $96.8 million recorded in 2021.
  • The sharpest move saw Goodwill & Intangibles surged 243.06% in 2021, then crashed 93.91% in 2022.
  • Year by year, Goodwill & Intangibles stood at $119.5 million in 2021, then skyrocketed by 74.07% to $208.0 million in 2022, then plummeted by 73.81% to $54.5 million in 2023, then soared by 225.41% to $177.2 million in 2024, then fell by 23.78% to $135.1 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for CCRN at $135.1 million in Q1 2025, $177.2 million in Q4 2024, and $54.5 million in Q4 2023.